reports
The Law Offices of Vincent Wong Reminds Investors of an Investigation ...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of MGC Diagnostics Corporation (NASDAQ: MGCD) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to affiliates of Altus Capital Partners, Inc. Under the terms of the deal, Clifton Bancorp shareholders will receive MGC Diagnostics shareholders will receive $11.03 in cash for each share of MGC Diagnostics stock they own. The investigation concerns whether the MGC ...
The Law Offices of Vincent Wong Notifies Investors of an Investigation...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of MGC Diagnostics Corporation (NASDAQ: MGCD) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to affiliates of Altus Capital Partners, Inc. Under the terms of the deal, Clifton Bancorp shareholders will receive MGC Diagnostics shareholders will receive $11.03 in cash for each share of MGC Diagnostics stock they own. The investigation concerns whether the MGC ...
INVESTOR ALERT: Brower Piven Commences An Investigation Into The Propo...
STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of MGC Diagnostics Corporation (Nasdaq: MGCD) (“MGC Diagnostics” or the “Company”) relating to the proposed buyout of MGC Diagnostics by Altus Capital Partners, Inc. Under the terms of the agreement, MGC Diagnostics shareholders are anticipated to receive $11.03 in cash for each share...
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investig...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased MGC Diagnostics Corporation (“MGC Diagnostics” or the “Company”) (NASDAQ:MGCD) stock prior to November 27, 2017. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of MGC Diagnostics to affiliates of Altus Capital Partners, Inc. Under the terms of the transaction, MGC Diagnostics shareholders will receive $11.03 in c...
SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Pr...
STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of MGC Diagnostics Corporation (Nasdaq: MGCD) (“MGC Diagnostics” or the “Company”) relating to the proposed buyout of MGC Diagnostics by Altus Capital Partners, Inc. Under the terms of the agreement, MGC Diagnostics shareholders are anticipated to receive $11.03 in cash for each share...
MGC DIAGNOSTICS CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. ...
WILMINGTON, Del.--(BUSINESS WIRE)-- Rigrodsky & Long, P.A.: Do you own shares of MGC Diagnostics Corporation (NASDAQ CM: MGCD)? Did you purchase any of your shares prior to November 27, 2017? Do you think the proposed buyout is fair? Do you want to discuss your rights? Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of MGC Diagnostics Corporation (“MGCD” or the “Company”) (NASDAQ CM: MGC...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Inve...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased MGC Diagnostics Corporation (“MGC Diagnostics” or the “Company”) (NASDAQ:MGCD) stock prior to November 27, 2017. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of MGC Diagnostics to affiliates of Altus Capital Partners, Inc. Under the terms of the transaction, MGC Diagnostics shareholders will receive $11.03 in c...
Ford Equity US Rating and Forecast Report
Ford Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.